Saturday, Sept. 6

7:00 a.m. - 9:00 a.m.
Interactive ID Fellows Session

Infectious Diseases 101: For Fellows Age 18-88


9:30 a.m. - 10:30 a.m.
Opening Keynote Session


10:45 a.m. - 11:45 a.m.
ICAAC Lecture


12:00 p.m. - 2:00 p.m.
Poster Sessions

Clinical Pharmacology of Antiviral and Antituberculosis Agents
Pharmacodynamics and Toxicokinetics of Colistin and Polymyxin
Pharmacokinetics/Pharmacodynamics of Anti-Infective Agents
Gram-Negative and Unusual Organisms, Biofilms, and Toxins
Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Situation in 2014
I'll take Potpourri for 1,000, Alex
Large Scale Epidemiological Surveillances of Multidrug Resistant Bacteria
Miscellaneous Resistance in Gram-Negatives
Molecular Characterization of Broad-Spectrum Beta-Lactamases
Susceptibility and Resistance in Anaerobes, Fastidious, and Atypical Organisms
Diagnosis and Susceptibility Testing of Mycobacterial Pathogens
Laboratory Diagnosis of Clostridium difficile Disease
Rapid Diagnosis of Enteric Pathogens
Novel Therapeutics, Approaches to Therapy, and Experimental Models for Bacteria and Fungi
Agents Targeting Clostridium difficile
Antimicrobial Peptides
Topoisomerase Inhibitors: Quinolones and Much More
Pneumococcal Infections
Surveillance and Interventions in Pediatric Patients
Novel Approaches to Active and Passive Immunization
Antimicrobial Stewardship: Epidemiology of Antimicrobial Use
Antimicrobial Stewardship: Interventions
Antimicrobial Stewardship: Interventions Targeting Specific Agents
Clostridium difficile Infections: Epidemiology
Clostridium difficile Infections: Outcomes
Clostridium difficile Infections: Treatment
Complications of Antimicrobial Use
Staphylococcus aureus Infections
Clinical Studies of Bloodstream Infections and Sepsis
Clinical Studies of Orthopaedic and Prosthetic Infections
Genital Tract and Sexually Transmitted Infections
Experimental Mycology
Viral and Fungal Challenges in Compromised Patients
Hepatitis and Other Viruses Associated with Gastrointestinal Illnessess (Norovirus, Rotavirus, CMV)


2:30 p.m. - 4:30 p.m.
Literature Review/New Agents Discovery Summary Session

Literature Review
Early New Antimicrobial Agents


4:45 p.m. - 6:45 p.m.

Old and New Anti-Infective Agents from a Pharmacokinetic/Pharmacodynamic Perspective
The Cutting Edge of Wound Infections and Biofilms: Innovative Science for Enhanced Therapeutics
Making Sense of our Relationships with Mucosal Commensals and Pathogens
Multidrug-Resistant (MDR) Gram-Negatives: On the Highway to Hell
Tickborne Infectious Diseases: Epidemiology, Diagnosis, Prevention, and Therapy
Time for a Revival of Natural Products?
What's New on Antiretroviral Therapy
Healthcare-Associated Fungal Infections
Preventing HAIs Using Topical Anti-Infectives and Antiseptics: A New Standard of Care?
The Latest on Maternal Immunization
Top 10 Mycology Papers for 2014
World-Wide Morbidity Due to Diarrheal Diseases and Current Approach to Limiting Their Impact in the Developing World
Hepatitis 2014: An Update


4:45 p.m. - 7:15 p.m.
Slide Sessions

Host Response and Immune-Based Therapeutics
Vaccine Safety and Compliance
Novel Infection Control Observations